| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
160,465 |
126,412 |
$10.48M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
31,134 |
28,116 |
$3.82M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,778 |
9,458 |
$2.80M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
26,786 |
24,074 |
$2.26M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
63,157 |
57,167 |
$1.75M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
44,893 |
40,005 |
$1.56M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,374 |
7,223 |
$803K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
34,050 |
11,974 |
$766K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,298 |
2,129 |
$578K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,088 |
1,028 |
$556K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,241 |
3,676 |
$474K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,707 |
11,704 |
$419K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
7,751 |
7,082 |
$409K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
22,157 |
8,023 |
$397K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,934 |
2,708 |
$392K |
| 71046 |
Radiologic examination, chest; 2 views |
8,701 |
7,967 |
$318K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,567 |
3,948 |
$315K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,223 |
2,222 |
$313K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,301 |
2,186 |
$294K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,299 |
1,875 |
$294K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,914 |
1,998 |
$253K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
622 |
575 |
$248K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,796 |
5,346 |
$212K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,228 |
2,947 |
$210K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,205 |
3,874 |
$201K |
| 97161 |
|
5,467 |
5,033 |
$188K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,379 |
3,265 |
$174K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,158 |
1,942 |
$173K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,168 |
4,355 |
$166K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,592 |
1,468 |
$159K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,224 |
2,067 |
$154K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,686 |
1,471 |
$153K |
| 76830 |
Ultrasound, transvaginal |
1,728 |
1,592 |
$123K |
| 93976 |
|
1,798 |
1,649 |
$123K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
879 |
500 |
$122K |
| G0008 |
Administration of influenza virus vaccine |
6,082 |
5,620 |
$112K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,061 |
1,966 |
$109K |
| 90791 |
Psychiatric diagnostic evaluation |
1,684 |
1,327 |
$106K |
| 86900 |
|
2,895 |
2,528 |
$97K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,778 |
1,750 |
$97K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,290 |
5,786 |
$93K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
11,051 |
7,686 |
$82K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
970 |
675 |
$82K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,528 |
1,525 |
$81K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,326 |
1,259 |
$81K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,633 |
5,304 |
$79K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,209 |
1,110 |
$75K |
| 80061 |
Lipid panel |
10,184 |
9,722 |
$72K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,344 |
3,232 |
$71K |
| 0002A |
|
2,518 |
2,412 |
$70K |
| 0001A |
|
2,695 |
2,598 |
$69K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,400 |
11,568 |
$66K |
| 29581 |
|
1,319 |
563 |
$66K |
| 80053 |
Comprehensive metabolic panel |
37,409 |
31,487 |
$65K |
| 97597 |
|
1,332 |
863 |
$62K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
16,171 |
14,547 |
$62K |
| 90686 |
|
7,747 |
7,068 |
$59K |
| 97113 |
|
1,817 |
729 |
$59K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
220 |
121 |
$57K |
| 93971 |
|
1,159 |
1,073 |
$56K |
| 99215 |
Prolong outpt/office vis |
1,039 |
998 |
$55K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
2,369 |
1,838 |
$47K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,587 |
4,193 |
$44K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,555 |
4,166 |
$44K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,392 |
1,679 |
$39K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,111 |
2,227 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
35,344 |
28,460 |
$38K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,315 |
1,292 |
$37K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
66 |
62 |
$36K |
| 97165 |
|
1,728 |
1,486 |
$33K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
143 |
132 |
$33K |
| 76801 |
|
390 |
344 |
$32K |
| Q3014 |
Telehealth originating site facility fee |
3,329 |
2,226 |
$31K |
| 76642 |
|
909 |
774 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
44,355 |
36,637 |
$29K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
416 |
379 |
$28K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,105 |
1,011 |
$27K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,412 |
2,848 |
$25K |
| 90677 |
|
746 |
738 |
$24K |
| 72100 |
|
1,641 |
1,520 |
$24K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,107 |
2,006 |
$24K |
| 96161 |
|
1,204 |
1,118 |
$23K |
| 96367 |
|
547 |
350 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
517 |
501 |
$23K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
334 |
322 |
$23K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
313 |
305 |
$22K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,549 |
2,408 |
$21K |
| 96127 |
|
5,847 |
4,902 |
$21K |
| 20610 |
|
242 |
226 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,421 |
9,829 |
$21K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,098 |
947 |
$20K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
298 |
297 |
$20K |
| 73562 |
|
2,361 |
1,969 |
$20K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
558 |
502 |
$19K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
168 |
159 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,198 |
12,471 |
$19K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
765 |
396 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
604 |
553 |
$19K |
| 85027 |
|
9,095 |
7,985 |
$17K |
| 97162 |
|
732 |
673 |
$17K |
| 87081 |
|
8,647 |
8,152 |
$17K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
137 |
122 |
$17K |
| 82728 |
|
3,136 |
2,959 |
$16K |
| 97035 |
|
3,297 |
1,322 |
$16K |
| 80305 |
|
17,352 |
13,193 |
$16K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,013 |
876 |
$16K |
| 90732 |
|
250 |
229 |
$15K |
| 72110 |
|
1,037 |
982 |
$15K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,863 |
1,762 |
$14K |
| 73630 |
|
2,131 |
1,921 |
$14K |
| 90651 |
|
413 |
372 |
$14K |
| 90473 |
|
356 |
349 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
261 |
241 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,953 |
1,794 |
$12K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
13 |
13 |
$12K |
| 99442 |
|
391 |
364 |
$12K |
| 73610 |
|
1,631 |
1,511 |
$12K |
| 99233 |
Prolong inpt eval add15 m |
408 |
222 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,572 |
6,314 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,766 |
7,895 |
$11K |
| 92557 |
|
251 |
233 |
$11K |
| 73030 |
|
1,380 |
1,220 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,618 |
5,728 |
$11K |
| 91322 |
|
163 |
163 |
$11K |
| 64721 |
|
16 |
13 |
$11K |
| 59025 |
Fetal non-stress test |
82 |
56 |
$10K |
| 12001 |
|
210 |
184 |
$10K |
| 64493 |
|
27 |
26 |
$10K |
| 82607 |
|
1,958 |
1,846 |
$9K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
45 |
25 |
$9K |
| 90480 |
|
569 |
557 |
$9K |
| 76775 |
|
279 |
264 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
104 |
99 |
$8K |
| 90678 |
|
28 |
28 |
$8K |
| 73502 |
|
1,134 |
1,047 |
$8K |
| 0004A |
|
692 |
637 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
110 |
109 |
$8K |
| 86592 |
|
2,181 |
2,022 |
$8K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
27 |
24 |
$7K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
374 |
355 |
$7K |
| 0124A |
|
576 |
537 |
$7K |
| 71250 |
|
170 |
166 |
$7K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,886 |
1,156 |
$7K |
| 84439 |
|
2,209 |
2,075 |
$7K |
| 83550 |
|
2,149 |
2,017 |
$7K |
| 77066 |
Tomosynthesis, mammo |
118 |
115 |
$7K |
| 73130 |
|
978 |
869 |
$6K |
| 97166 |
|
353 |
307 |
$6K |
| 84702 |
|
868 |
663 |
$6K |
| 83655 |
|
1,449 |
1,355 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,041 |
866 |
$6K |
| 72050 |
|
359 |
342 |
$6K |
| 87077 |
|
5,972 |
5,508 |
$6K |
| 90670 |
|
1,995 |
1,797 |
$6K |
| 73110 |
|
908 |
825 |
$6K |
| 97116 |
|
1,361 |
739 |
$5K |
| 83540 |
|
2,267 |
2,131 |
$5K |
| 85610 |
|
6,043 |
4,057 |
$5K |
| 82950 |
|
1,182 |
1,127 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
58 |
55 |
$5K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
25 |
25 |
$5K |
| 83735 |
|
9,114 |
6,560 |
$5K |
| 0054A |
|
331 |
324 |
$5K |
| 10060 |
|
37 |
37 |
$5K |
| 77080 |
|
146 |
143 |
$5K |
| 90656 |
|
556 |
555 |
$5K |
| 73140 |
|
341 |
329 |
$5K |
| 64615 |
|
64 |
62 |
$4K |
| 62323 |
|
31 |
30 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,711 |
4,297 |
$4K |
| 86703 |
|
2,034 |
1,860 |
$4K |
| 87205 |
|
5,247 |
4,816 |
$4K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
14 |
13 |
$4K |
| 71271 |
|
83 |
82 |
$4K |
| 96160 |
|
170 |
170 |
$4K |
| 86803 |
|
1,668 |
1,549 |
$4K |
| 99223 |
Prolong inpt eval add15 m |
55 |
52 |
$4K |
| 82746 |
|
725 |
681 |
$4K |
| 87186 |
|
3,245 |
3,003 |
$4K |
| C1776 |
Joint device (implantable) |
410 |
381 |
$4K |
| 99024 |
|
287 |
240 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
365 |
347 |
$4K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
16 |
14 |
$4K |
| 86618 |
|
899 |
852 |
$3K |
| 99381 |
|
46 |
45 |
$3K |
| 90662 |
|
657 |
618 |
$3K |
| 86140 |
|
3,682 |
3,169 |
$3K |
| 81025 |
|
7,420 |
6,644 |
$3K |
| 93017 |
|
99 |
94 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
224 |
214 |
$3K |
| G0009 |
Administration of pneumococcal vaccine |
277 |
251 |
$3K |
| 91320 |
|
284 |
274 |
$3K |
| 0072A |
|
139 |
75 |
$3K |
| 87340 |
|
1,953 |
1,802 |
$3K |
| 0071A |
|
135 |
76 |
$3K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
315 |
307 |
$3K |
| 87631 |
|
609 |
579 |
$3K |
| 84153 |
|
353 |
342 |
$3K |
| 97018 |
|
1,051 |
434 |
$3K |
| 76536 |
|
49 |
49 |
$3K |
| 74018 |
|
172 |
154 |
$3K |
| 82570 |
|
5,105 |
3,484 |
$3K |
| 82043 |
|
2,289 |
2,160 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
38 |
37 |
$2K |
| 69209 |
|
498 |
467 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
151 |
134 |
$2K |
| 85651 |
|
2,766 |
2,418 |
$2K |
| 83880 |
|
1,514 |
1,319 |
$2K |
| 0031A |
|
94 |
88 |
$2K |
| 31575 |
|
15 |
15 |
$2K |
| 80076 |
|
657 |
618 |
$2K |
| 83690 |
|
6,305 |
5,463 |
$2K |
| 58300 |
|
52 |
39 |
$2K |
| 87070 |
|
1,510 |
1,389 |
$2K |
| 72141 |
|
12 |
12 |
$2K |
| 87522 |
Neg quan hep c or qual rna |
111 |
101 |
$2K |
| 99205 |
Prolong outpt/office vis |
26 |
24 |
$2K |
| 99490 |
Ccm add 20min |
44 |
43 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
52 |
52 |
$2K |
| 93970 |
|
14 |
14 |
$2K |
| 81003 |
|
8,246 |
6,969 |
$2K |
| 82105 |
|
134 |
129 |
$1K |
| 86762 |
|
1,213 |
1,112 |
$1K |
| A9270 |
Non-covered item or service |
8,166 |
6,595 |
$1K |
| 99188 |
|
104 |
96 |
$1K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
168 |
163 |
$1K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,770 |
1,595 |
$1K |
| 99307 |
|
96 |
74 |
$1K |
| 90734 |
|
213 |
188 |
$1K |
| 84403 |
|
105 |
97 |
$1K |
| G0378 |
Hospital observation service, per hour |
1,145 |
861 |
$968.76 |
| 81002 |
|
3,651 |
3,375 |
$940.28 |
| 0064A |
|
65 |
43 |
$930.46 |
| 71101 |
|
145 |
133 |
$808.27 |
| 92567 |
|
593 |
563 |
$786.45 |
| 97014 |
|
67 |
26 |
$782.11 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
25 |
25 |
$754.32 |
| 99406 |
|
46 |
41 |
$700.80 |
| 81000 |
|
3,311 |
2,958 |
$682.14 |
| 99222 |
Initial hospital care, per day, moderate complexity |
14 |
13 |
$676.88 |
| D1120 |
Prophylaxis - child |
13 |
13 |
$655.80 |
| 86706 |
|
197 |
183 |
$655.69 |
| 72070 |
|
25 |
25 |
$653.75 |
| 92504 |
|
298 |
283 |
$649.00 |
| 87280 |
|
475 |
437 |
$648.19 |
| 99310 |
Prolong nursin fac eval 15m |
22 |
22 |
$641.49 |
| 90461 |
|
29 |
19 |
$639.36 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
54 |
40 |
$638.40 |
| 82962 |
|
7,984 |
4,766 |
$633.21 |
| 77065 |
Tomosynthesis, mammo |
14 |
12 |
$592.81 |
| 81001 |
|
4,190 |
3,545 |
$552.14 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,290 |
1,191 |
$549.37 |
| 82784 |
|
193 |
184 |
$529.68 |
| 72040 |
|
129 |
123 |
$523.79 |
| 83001 |
|
50 |
49 |
$500.87 |
| 90716 |
|
325 |
299 |
$490.02 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
42 |
38 |
$486.82 |
| 90715 |
|
3,261 |
3,019 |
$470.73 |
| 87641 |
|
72 |
70 |
$445.49 |
| 85018 |
|
1,140 |
993 |
$439.19 |
| 74022 |
|
89 |
83 |
$429.95 |
| 99496 |
|
15 |
12 |
$428.80 |
| 96381 |
|
32 |
32 |
$424.96 |
| 87484 |
|
81 |
79 |
$424.68 |
| 86850 |
|
2,960 |
2,580 |
$423.62 |
| 0012A |
|
25 |
25 |
$423.24 |
| 83986 |
|
2,135 |
1,155 |
$422.92 |
| 87469 |
|
81 |
79 |
$421.68 |
| 87468 |
|
81 |
79 |
$421.68 |
| 88342 |
|
509 |
468 |
$414.65 |
| 87430 |
|
373 |
358 |
$399.26 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,203 |
1,102 |
$396.73 |
| 84484 |
|
4,749 |
4,062 |
$383.33 |
| 83516 |
|
92 |
81 |
$381.20 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
16 |
$350.00 |
| 84100 |
|
182 |
116 |
$328.37 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
28 |
$326.25 |
| 84315 |
|
2,124 |
1,146 |
$307.34 |
| 82550 |
|
279 |
249 |
$305.25 |
| 88307 |
|
77 |
68 |
$275.81 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,744 |
2,429 |
$272.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,411 |
4,388 |
$252.00 |
| 86364 |
|
69 |
68 |
$244.41 |
| 87478 |
|
42 |
40 |
$243.60 |
| 81015 |
|
299 |
282 |
$221.26 |
| 72170 |
|
70 |
69 |
$199.82 |
| 87640 |
|
69 |
68 |
$191.45 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,125 |
3,166 |
$183.19 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,728 |
2,140 |
$181.36 |
| 0134A |
|
40 |
37 |
$169.50 |
| 87075 |
|
510 |
465 |
$165.92 |
| 84703 |
|
328 |
309 |
$164.74 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
14 |
14 |
$159.66 |
| 86038 |
|
49 |
49 |
$159.23 |
| 76376 |
|
739 |
714 |
$157.03 |
| 85730 |
|
269 |
230 |
$152.21 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
13 |
13 |
$147.98 |
| 97164 |
|
14 |
12 |
$147.48 |
| 86787 |
|
90 |
83 |
$146.84 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
27 |
24 |
$130.80 |
| J2704 |
Injection, propofol, 10 mg |
10,523 |
9,368 |
$113.79 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
13 |
13 |
$112.90 |
| 69210 |
|
12 |
12 |
$103.70 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
53 |
51 |
$102.26 |
| 36591 |
|
23 |
16 |
$102.09 |
| 85379 |
|
758 |
676 |
$100.92 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$99.28 |
| 83993 |
|
12 |
12 |
$98.15 |
| 84146 |
|
13 |
12 |
$96.90 |
| 87449 |
|
53 |
51 |
$96.46 |
| 87040 |
|
445 |
384 |
$84.72 |
| 0111A |
|
13 |
12 |
$74.40 |
| 82075 |
|
586 |
478 |
$73.92 |
| 73560 |
|
35 |
25 |
$72.63 |
| 87807 |
|
16 |
16 |
$70.26 |
| 83605 |
|
894 |
784 |
$62.30 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
562 |
492 |
$60.33 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,240 |
6,476 |
$56.63 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,269 |
4,397 |
$55.13 |
| J2060 |
Injection, lorazepam, 2 mg |
2,219 |
1,808 |
$52.49 |
| 73080 |
|
12 |
12 |
$50.28 |
| 87324 |
|
39 |
39 |
$49.66 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
206 |
198 |
$48.84 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,686 |
7,829 |
$47.13 |
| 87427 |
|
14 |
13 |
$46.84 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
524 |
479 |
$45.86 |
| 86901 |
|
2,905 |
2,538 |
$42.60 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,769 |
4,975 |
$39.81 |
| 87045 |
|
14 |
13 |
$37.76 |
| 87046 |
|
14 |
13 |
$37.76 |
| 83721 |
|
15 |
13 |
$37.48 |
| 80178 |
|
14 |
14 |
$32.70 |
| 82150 |
|
12 |
12 |
$32.60 |
| 80164 |
|
14 |
12 |
$29.86 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
34 |
34 |
$26.62 |
| 87400 |
|
136 |
135 |
$26.46 |
| 90744 |
|
299 |
253 |
$26.14 |
| 86430 |
|
12 |
12 |
$23.20 |
| 84460 |
|
13 |
12 |
$21.14 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
2,466 |
2,271 |
$20.55 |
| 82565 |
|
25 |
24 |
$19.96 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
999 |
734 |
$19.08 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
48 |
48 |
$14.19 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,472 |
1,339 |
$13.12 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,103 |
6,823 |
$12.59 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,279 |
5,932 |
$12.54 |
| 87339 |
|
491 |
430 |
$11.71 |
| 86308 |
|
14 |
12 |
$10.58 |
| 82948 |
|
552 |
394 |
$8.70 |
| A6209 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
697 |
405 |
$8.19 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,496 |
9,696 |
$6.93 |
| 82272 |
|
12 |
12 |
$6.90 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,237 |
1,062 |
$5.30 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,416 |
6,487 |
$5.14 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,127 |
898 |
$4.24 |
| 82077 |
|
1,341 |
1,210 |
$3.52 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
915 |
796 |
$3.14 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
6,358 |
5,334 |
$1.71 |
| 83615 |
|
22 |
19 |
$1.14 |
| C9113 |
Injection, pantoprazole sodium, per vial |
306 |
210 |
$0.00 |
| 90633 |
|
1,215 |
1,126 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
714 |
674 |
$0.00 |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
615 |
332 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
291 |
206 |
$0.00 |
| 76942 |
|
541 |
476 |
$0.00 |
| 90707 |
|
418 |
400 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,747 |
5,375 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,205 |
1,057 |
$0.00 |
| 91300 |
|
6,112 |
3,886 |
$0.00 |
| 90710 |
|
103 |
92 |
$0.00 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
41 |
37 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
45 |
38 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
118 |
99 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
473 |
433 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
121 |
91 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
581 |
485 |
$0.00 |
| 90700 |
|
331 |
307 |
$0.00 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
318 |
223 |
$0.00 |
| 91311 |
|
109 |
103 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
102 |
86 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
95 |
82 |
$0.00 |
| 80143 |
|
29 |
25 |
$0.00 |
| 91321 |
|
42 |
42 |
$0.00 |
| 91312 |
|
321 |
295 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
193 |
92 |
$0.00 |
| 64447 |
|
109 |
104 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
24 |
24 |
$0.00 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
35 |
29 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
821 |
720 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
15 |
12 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
38 |
38 |
$0.00 |
| 80179 |
|
14 |
12 |
$0.00 |
| 99152 |
|
29 |
25 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,785 |
1,480 |
$0.00 |
| 90697 |
|
744 |
728 |
$0.00 |
| 96376 |
|
1,963 |
1,320 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,452 |
1,263 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
487 |
440 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
273 |
249 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,467 |
1,120 |
$0.00 |
| 90680 |
|
1,657 |
1,531 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
207 |
183 |
$0.00 |
| J3490 |
Unclassified drugs |
1,596 |
1,431 |
$0.00 |
| 91305 |
|
300 |
288 |
$0.00 |
| C1769 |
Guide wire |
391 |
350 |
$0.00 |
| 90619 |
|
36 |
36 |
$0.00 |
| 90698 |
|
700 |
601 |
$0.00 |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
539 |
291 |
$0.00 |
| 36416 |
|
563 |
522 |
$0.00 |
| 90474 |
|
1,215 |
1,104 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
322 |
264 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
536 |
477 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
14 |
14 |
$0.00 |
| 94760 |
|
77 |
63 |
$0.00 |
| 90696 |
|
40 |
40 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
54 |
53 |
$0.00 |
| 90647 |
|
238 |
192 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
27 |
25 |
$0.00 |
| 1123F |
|
137 |
135 |
$0.00 |
| 91301 |
|
1,742 |
661 |
$0.00 |
| 88341 |
|
15 |
12 |
$0.00 |
| 88304 |
|
15 |
13 |
$0.00 |
| 64494 |
|
25 |
24 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
33 |
26 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
76 |
72 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
13 |
13 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
18 |
17 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
47 |
42 |
$0.00 |
| 90381 |
|
31 |
31 |
$0.00 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
20 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
329 |
239 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
26 |
26 |
$0.00 |
| 64415 |
|
25 |
25 |
$0.00 |
| 91307 |
|
54 |
28 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
15 |
12 |
$0.00 |